Vertex Pharmaceuticals
Trade Vertex Pharmaceuticals 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About VRTX
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis.
VRTX Key Statistics
Stock Snapshot
The current Vertex Pharmaceuticals(VRTX) stock price is $548.05, with a market capitalization of 138.92B. The stock trades at a price-to-earnings (P/E) ratio of 31.88.
During the trading session on 2026-08-22, Vertex Pharmaceuticals(VRTX) shares reached a daily high of $555.31 and a low of $540.05. At a current price of $548.05, the stock is +1.5% higher than the low and still -1.3% under the high.
Trading activity shows a volume of 1.07M, compared to an average daily volume of 1.3M.
The stock's 52-week range extends from a low of $374.17 to a high of $555.32.
The stock's 52-week range extends from a low of $374.17 to a high of $555.32.
VRTX News
The Invesco Nasdaq Biotechnology ETF (IBBQ +1.37%) offers lower costs and broader market diversification, while the VanEck Biotech ETF (BBH +1.74%) provides a m...
Explore the exciting world of Vertex Pharmaceuticals (NASDAQ: VRTX) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the...
Vertex Pharmaceuticals recently raised its full-year 2026 revenue guidance, reflecting continued leadership in cystic fibrosis and expanding traction in sickle...
Analyst ratings
75%
of 32 ratingsMore VRTX News
Vertex Pharmaceuticals Inc. (VRTX) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter,...
Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions Subscribe to TipRanks Smart Investor Newsletter, and...
Global bond yields have pushed higher this month as investors demand more compensation for inflation risk. When safer assets feel choppy, owning low risk leader...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.